• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Precision medicine data on DS-8201 pharmaasia
    June 13, 2017
    Preliminary results from phase 1 study demonstrate a 46.7 percent overall response rate and 100 percent disease control rate with smart chemotherapy DS-8201 in a subgroup analysis of HER2-expressing metastatic breast cancer pre-treated with T-DM1 and pert
  • BMS, GRAIL in Precision Medicine Pact contractpharma
    March 02, 2017
    BMS investment aims to advance pipeline with highly sensitive blood tests that detect cancer early
Previous page 1 2 3 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service